KD Logo

Analysts review Evolent Health Inc’s rating

In a filing, Evolent Health Inc revealed its PRESIDENT McCarthy Daniel Joseph unloaded Company’s shares for reported $0.73 million on Aug 22 ’24. In the deal valued at $30.89 per share,23,693 shares were sold. As a result of this transaction, McCarthy Daniel Joseph now holds 198,809 shares worth roughly $2.46 million.

Then, McCarthy Daniel Joseph sold 10,469 shares, generating $339,008 in total proceeds. Upon selling the shares at $32.38, the PRESIDENT now owns 188,340 shares.

Before that, Weinberg Jonathan sold 42,140 shares. Evolent Health Inc shares valued at $1,314,706 were divested by the General Counsel at a price of $31.20 per share. As a result of the transaction, Weinberg Jonathan now holds 167,027 shares, worth roughly $2.07 million.

Needham initiated its Evolent Health Inc [EVH] rating to a Buy in a research note published on January 10, 2025; the price target was $15. A number of analysts have revised their coverage, including BTIG Research’s analysts, who remained covering the stock and in early December has reiterated a ‘”a Buy”‘ rating for it. Stephens also remained covering EVH and has decreased its forecast on November 08, 2024 with a “an Equal-weight” recommendation from previously “an Overweight” rating. KeyBanc Capital Markets started covering the stock on October 11, 2024. It rated EVH as “an Overweight”.

Price Performance Review of EVH

On Monday, Evolent Health Inc [NYSE:EVH] saw its stock fall -1.20% to $12.39. Over the last five days, the stock has gained 4.29%. Evolent Health Inc shares have risen nearly 10.13% since the year began. Nevertheless, the stocks have fallen -62.56% over the past one year. While a 52-week high of $35.00 was reached on 01/10/25, a 52-week low of $10.53 was recorded on 01/03/25. SMA at 50 days reached $13.61, while 200 days put it at $22.67.

Levels Of Support And Resistance For EVH Stock

The 24-hour chart illustrates a support level at 12.10, which if violated will result in even more drops to 11.80. On the upside, there is a resistance level at 12.65. A further resistance level may holdings at 12.90. The Relative Strength Index (RSI) on the 14-day chart is 51.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 26.92%. Stochastics %K at 84.66% indicates the stock is a selling.

How much short interest is there in Evolent Health Inc?

A steep rise in short interest was recorded in Evolent Health Inc stocks on 2024-12-13, dropping by -1.06 million shares to a total of 9.76 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 10.82 million shares. There was a decline of -10.88%, which implies that there is a negative sentiment for the stock.

Most Popular